Search Results for /files/articlefiles/ajmc2002aprilharjivan318.pdf?slug=files%2Farticlefiles%2Fajmc2002aprilharjivan318.pdf

Results for "/files/articlefiles/ajmc2002aprilharjivan318.pdf?slug=files%2Farticlefiles%2Fajmc2002aprilharjivan318.pdf"

What We're Reading: HHS OIG Cites MA Plans; Shifts in Place of Death; FDA Warns Drugmaker

December 12, 2019

The HHS’ Office of the Inspector General (OIG) released a report that says Medicare Advantage (MA) plans received an estimated $6.7 billion in 2017 after adding diagnoses to patients' files that were not supported by their medical records; more Americans are dying at home rather than in hospitals or nursing homes; the FDA warned Alkermes, maker of Vivitrol, a long-acting antiaddiction medication, that its printed advertisement does not include the risk of an increased chance of a “potentially fatal” opioid overdose as the effects wear off.

What We're Reading: Purdue Pharma Files for Bankruptcy; Rise in Uninsured Immigrants; Spiked CBD in Maryland

September 16, 2019

Oxycontin manufacturer Purdue Pharma files for bankruptcy; the rise in uninsured immigrants may be associated with fear of the Trump administration's crackdown on immigrants; an investigation has found that some cannabidiol (CBD) products are being spiked in Maryland.

What We're Reading: Missouri Abortion Clinic to Stay Open; Red Flags for Esketamine; Opioid Maker Files for Bankruptcy

June 11, 2019

Missouri's only abortion clinic will stay open after a state circuit court judge issued a preliminary injunction; the FDA overlooked red flags for esketamine after Janssen provided only limited data about the drug's safety and efficacy; opiod manufacturer Insys has filed for bankruptcy proctection after agreeing to pay $225 million to settle a federal investigation over its marketing of fentanyl.

Amarin Files Supplemental NDA With FDA for Vascepa Based on REDUCE-IT Results

April 04, 2019

Based on recently published results of the REDUCE-IT study, pharmacuetical company Amarin has submitted a supplemental new drug application (sNDA) to the FDA for an expanded label for its leading drug Vascepa. Also, the American Diabetes Association has included the drug in a mid-year update to its 2019 Standards of Medical Care in Diabetes.

COA Protests Against the Medicare Part B Sequester Cut, Files Lawsuit

July 05, 2018

The Community Oncology Alliance (COA) has filed a lawsuit in the US District Court for the District of Columbia, stating that the 2% sequester cut to Medicare Part B drug reimbursement is unconstitutional and illegal, and that it can harm patient care and have a huge impact on the communityc ancer care system.

What We're Reading: Medicaid Lifetime Limits; Long-Term Care; More States File Opioid Lawsuits

May 16, 2018

The Trump administration confirms it will not approve state requests to impose lifetime limits on Medicaid benefits; a significant number of young adults are providing long-term care for older loved ones and are more likely to be stressed by the caregiving than older counterparts; 5 more states file lawsuit against Purdue Pharma for its alleged role in the opioid epidemic, and Florida files lawsuit against multiple painkiller makers and drug distributors.

Geographic Access to Endocrinologists for Florida's Publicly Insured Children With Diabetes

March 31, 2018

Enrollment, claims, and spatial data are used to demonstrate the importance of outreach strategies for families in rural areas who have children with diabetes. Spatial barriers, alone, do not fully elucidate racial/ethnic disparities in pediatric diabetes for street-level location. (For Tables and the Figure, please access the PDF on the last page.)